News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
324,434 Results
Type
Article (29150)
Company Profile (76)
Press Release (295200)
Multimedia
Podcasts (80)
Webinars (7)
Section
Business (89766)
Career Advice (517)
Deals (11853)
Drug Delivery (83)
Drug Development (46305)
Employer Resources (46)
FDA (6953)
Job Trends (7333)
News (146457)
Policy (15207)
Tag
2027 BioCapital Standard (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (4)
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (1932)
Academic (1)
Accelerated approval (43)
ADA (14)
Adcomms (20)
Allergies (52)
Alliances (24087)
ALS (87)
Alzheimer's disease (790)
Antibody-drug conjugate (ADC) (621)
Approvals (7349)
Artificial intelligence (403)
ASCO (334)
Autoimmune disease (205)
Automation (17)
Bankruptcy (110)
Belgium (2)
Best Places to Work (6432)
BIO (42)
Biologics (5)
BIOSECURE Act (16)
Biosimilars (152)
BioSpace Insights (65)
Biotechnology (67)
Bispecific (2)
Bladder cancer (228)
Brain cancer (91)
Breast cancer (915)
Cancer (7174)
Cardiovascular disease (165)
Career advice (462)
Career pathing (11)
CAR-T (328)
CDC (40)
CDMO (82)
Celiac Disease (2)
Cell therapy (697)
Cervical cancer (61)
Clinical research (40257)
Collaboration (1305)
Commercialization (7)
Company closure (6)
Compensation (500)
Complete response letters (45)
COVID-19 (1465)
CRISPR (58)
C-suite (615)
Cystic fibrosis (56)
Data (5374)
Decentralized trials (3)
Denatured (18)
Depression (65)
Dermatology (58)
Diabetes (227)
Diagnostics (4283)
Digital health (30)
Diversity (7)
Diversity, equity & inclusion (16)
Drug discovery (164)
Drug pricing (146)
Drug shortages (11)
Duchenne muscular dystrophy (81)
Earnings (28069)
Editorial (32)
Employer branding (6)
Employer resources (42)
Events (52066)
Executive appointments (512)
FDA (9213)
Fibrodysplasia Ossificans Progressiva (7)
Fragile X (1)
Friedreich's ataxia (9)
Frontotemporal dementia (14)
Funding (1067)
Gene editing (102)
Generative AI (23)
Gene therapy (271)
GLP-1 (358)
Government (3333)
Grass and pollen (2)
Guidances (171)
Healthcare (10866)
Hematology (168)
HIV (65)
Huntington's disease (8)
IgA nephropathy (38)
Immunology and inflammation (143)
Immuno-oncology (130)
Indications (152)
Infectious disease (1642)
Inflammatory bowel disease (92)
Inflation Reduction Act (8)
Influenza (61)
Intellectual property (156)
Interviews (81)
IPO (5997)
IRA (28)
Job creations (1135)
Job search strategy (403)
JPM (39)
Kidney cancer (27)
Labor market (35)
Layoffs (236)
Leadership (9)
Legal (2681)
Licensing (17)
Liver cancer (114)
Longevity (16)
Lung cancer (1000)
Lymphoma (472)
Machine learning (39)
Management (15)
Manufacturing (553)
Marketing (8)
MASH (86)
Medical affairs (2)
Medical device (3572)
Medtech (3627)
Mergers & acquisitions (6377)
Metabolic disorders (571)
mRNA (181)
Multiple sclerosis (80)
NASH (1)
Netherlands (1)
Neurodegenerative disease (166)
Neuropsychiatric disorders (32)
Neuroscience (1347)
NextGen: Class of 2026 (3587)
Non-profit (3623)
Now hiring (19)
Obesity (240)
Opinion (149)
Ovarian cancer (263)
Pain (129)
Pancreatic cancer (404)
Parkinson's disease (110)
Partnered (17)
Patents (340)
Patient advocacy (1)
Patient recruitment (477)
Patient selection (3)
Peanut (8)
People (26991)
Peptides (1)
Pharmaceutical (13)
Pharmacy benefit managers (21)
Phase 1 (14305)
Phase 2 (17331)
Phase 3 (12631)
Pipeline (6034)
Policy (221)
Postmarket research (1313)
Preclinical (6011)
Press Release (25)
Prostate cancer (379)
Psychedelics (33)
Radiopharmaceuticals (373)
Rare diseases (511)
Real estate (2082)
Recruiting (19)
Regulatory (12706)
Reports (22)
Research institute (1885)
Resumes & cover letters (62)
Rett syndrome (3)
RNA editing (9)
RSV (36)
Schizophrenia (70)
Series A (135)
Series B (98)
Sickle cell disease (62)
Special edition (11)
Spinal muscular atrophy (54)
Sponsored (22)
Startups (1566)
State (2)
Stomach cancer (22)
Supply chain (63)
Tariffs (66)
The Weekly (62)
Vaccines (653)
Venture capital (71)
Weight loss (146)
Women's health (90)
Worklife (3)
Date
Today (33)
Last 7 days (227)
Last 30 days (1002)
Last 365 days (14401)
2026 (10232)
2025 (14268)
2024 (16788)
2023 (19042)
2022 (25208)
2021 (26817)
2020 (25862)
2019 (23470)
2018 (17426)
2017 (14179)
2016 (14046)
2015 (16280)
2014 (12288)
2013 (9822)
2012 (10263)
2011 (10854)
2010 (9650)
Location
Africa (350)
Alabama (29)
Alaska (3)
Arizona (161)
Arkansas (7)
Asia (21519)
Australia (3789)
California (6919)
Canada (1949)
China (1302)
Colorado (296)
Connecticut (327)
Delaware (305)
Europe (41620)
Florida (1047)
Georgia (191)
Hawaii (1)
Idaho (27)
Illinois (623)
India (52)
Indiana (378)
Iowa (17)
Japan (360)
Kansas (46)
Kentucky (36)
Louisiana (34)
Maine (8)
Maryland (927)
Massachusetts (4356)
Michigan (88)
Minnesota (257)
Mississippi (4)
Missouri (106)
Montana (17)
Nebraska (11)
Nevada (82)
New Hampshire (47)
New Jersey (2136)
New Mexico (22)
New York (2219)
North Carolina (572)
North Dakota (2)
Northern California (3666)
Ohio (191)
Oklahoma (5)
Oregon (14)
Pennsylvania (1243)
Puerto Rico (14)
Rhode Island (17)
South America (397)
South Carolina (26)
South Dakota (2)
Southern California (2765)
Tennessee (97)
Texas (1535)
United States (24597)
Utah (149)
Vermont (2)
Virginia (141)
Washington D.C. (33)
Washington State (717)
West Virginia (3)
Wisconsin (100)
Wyoming (1)
324,434 Results for "national colorectal cancer roundtable nccrt".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Cancer
BioNTech halts mid-stage trial of personalized mRNA vaccine in colorectal cancer
Shares of Germany-based BioNTech were down as much as 8% Friday after announcing a Phase 2 trial of autogene cevumeran would be discontinued for futility. The news follows Merck and Moderna’s Phase 3 win last week for their cancer vaccine plus Keytruda in melanoma.
August 28, 2026
·
2 min read
·
Heather McKenzie
Press Releases
Marking National Colorectal Cancer Awareness Month, Privia Health Program Achieves 84% Colorectal Cancer Screening Rate Through Industry Collaboration
March 4, 2026
·
5 min read
Press Releases
FDA Clears CU Anschutz Clinical Trial Using Engineered Immune Cells to Fight Colorectal Cancer
September 10, 2026
·
5 min read
Press Releases
Guardant Health’s Shield Blood Test Covered by Carelon Health Services for Colorectal Cancer Screening
September 1, 2026
·
6 min read
Press Releases
Co-Diagnostics to Participate in Global Health Roundtable on Ebola and Outbreak Innovation
September 21, 2026
·
5 min read
Press Releases
Oncolytics Biotech® Announces Positive Preclinical Results Combining Pelareorep with a Pan-RAS Inhibitor in Colorectal Cancer
September 10, 2026
·
6 min read
Press Releases
Signatera™ Receives Regulatory Approval in Japan for Colorectal Cancer
June 24, 2026
·
5 min read
Cancer
BMS’ Krazati kneels to chemo in confirmatory colorectal cancer trial
Patients treated with Bristol Myers Squibb’s Krazati in combination with cetuximab saw shorter median overall and progression-free survival than comparators on chemotherapy.
July 7, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Co-Diagnostics Participates in Medical Devices and Innovations Roundtable Media Event
August 18, 2026
·
4 min read
Press Releases
Oncolytics Biotech® Aligns with FDA on Registrational Path for Second-Line RAS-Mutant MSS Colorectal Cancer
August 18, 2026
·
6 min read
1 of 32,444
Next
